000 | 01381 a2200373 4500 | ||
---|---|---|---|
005 | 20250511180407.0 | ||
264 | 0 | _c19921110 | |
008 | 199211s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTesta, J E | |
245 | 0 | 0 |
_aLoss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. _h[electronic resource] |
260 |
_bCancer research _cOct 1992 |
||
300 |
_a5597-603 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAllantois |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xenzymology |
650 | 0 | 4 | _aChick Embryo |
650 | 0 | 4 | _aChorion |
650 | 0 | 4 |
_aCollagenases _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xenzymology |
650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aReceptors, Cell Surface _xgenetics |
650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
650 | 0 | 4 | _aTissue Inhibitor of Metalloproteinase-2 |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aUrokinase-Type Plasminogen Activator _xmetabolism |
773 | 0 |
_tCancer research _gvol. 52 _gno. 20 _gp. 5597-603 |
|
999 |
_c1334034 _d1334034 |